Zacks Investment Research
17 Nov 2026, 18:46 UTC · 7h ago
3 Reasons Growth Investors Will Love ICU Medical (ICUI)
Impact · against what's priced in
The article identifies ICU Medical as a strong growth candidate based on its projected EPS growth and positive cash flow. However, as these are backward-looking or current-state metrics typical of a growth-oriented valuation, they offer little catalyst for immediate price movement.
- ICUI+0.10
No priced-in read yet
- In context
The company is projected to grow EPS by 13.9%, outperforming the industry average of 8.7%, while maintaining a 4.9% year-over-year cash flow growth.
Read from the article alone

Search tags




